Smoking cessation and the general practice pharmacist

Louise S. Deeks, Sam Kosari, Anne Develin, Gregory M. Peterson, Mark Naunton

Research output: Contribution to journalArticle

Abstract

IntroductionRoles for pharmacists in general practice are developing in Australia. It is known that pharmacists can provide effective smoking cessation services in other settings but evidence in general practice is lacking.AimTo determine whether a pharmacist can provide effective smoking cessation services within general practice.MethodData from smoking cessation consultations were obtained for 66 consecutive patients seen by one practice pharmacist. The pharmacist tailored interventions to the individual. Medication was offered in collaboration with community pharmacists and general practitioners. Quit coaching, based on motivational interviewing, was conducted. Smoking status was ascertained at least 6 months after the intended quit date and verified by a carbon monoxide breath test where possible.ResultsThe patients' median age was 43 years (range 19-74 years); 42 were females (64%). At baseline, the median (i) number of pack years smoked was 20 (range: 1-75); (ii) Fagerstrom Test of dependence score was 6 (1-10); and (iii) number of previous quit attempts was 3 (0-10). Follow-up after at least 6 months determined a self-reported point prevalence abstinence rate of 30% (20/66). Of all patients who reported to be abstinent, 65% (13/20) were tested for carbon monoxide breath levels and were all below 7 ppm. The biochemically verified smoking abstinence rate was therefore 20% overall (13/66). Successful quit attempts were associated with varenicline recommendation (69% v 25%), increased median number of practice pharmacist consultations (4 v 2 per patient) and mental health diagnosis (85% v 51%).ConclusionOur observed abstinence rate was comparable or better than those obtained by practice nurses, community pharmacists and outpatient pharmacists, indicating the general practice pharmacist provided an effective smoking cessation intervention. A larger randomised trial is warranted.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalJournal of Smoking Cessation
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Smoking Cessation
Pharmacists
General Practice
Carbon Monoxide
Referral and Consultation
Smoking
Motivational Interviewing
Breath Tests
General Practitioners
Mental Health
Outpatients
Nurses

Cite this

Deeks, Louise S. ; Kosari, Sam ; Develin, Anne ; Peterson, Gregory M. ; Naunton, Mark. / Smoking cessation and the general practice pharmacist. In: Journal of Smoking Cessation. 2019 ; pp. 1-4.
@article{81b7cea42b694998b4bd66f97f9afabd,
title = "Smoking cessation and the general practice pharmacist",
abstract = "IntroductionRoles for pharmacists in general practice are developing in Australia. It is known that pharmacists can provide effective smoking cessation services in other settings but evidence in general practice is lacking.AimTo determine whether a pharmacist can provide effective smoking cessation services within general practice.MethodData from smoking cessation consultations were obtained for 66 consecutive patients seen by one practice pharmacist. The pharmacist tailored interventions to the individual. Medication was offered in collaboration with community pharmacists and general practitioners. Quit coaching, based on motivational interviewing, was conducted. Smoking status was ascertained at least 6 months after the intended quit date and verified by a carbon monoxide breath test where possible.ResultsThe patients' median age was 43 years (range 19-74 years); 42 were females (64{\%}). At baseline, the median (i) number of pack years smoked was 20 (range: 1-75); (ii) Fagerstrom Test of dependence score was 6 (1-10); and (iii) number of previous quit attempts was 3 (0-10). Follow-up after at least 6 months determined a self-reported point prevalence abstinence rate of 30{\%} (20/66). Of all patients who reported to be abstinent, 65{\%} (13/20) were tested for carbon monoxide breath levels and were all below 7 ppm. The biochemically verified smoking abstinence rate was therefore 20{\%} overall (13/66). Successful quit attempts were associated with varenicline recommendation (69{\%} v 25{\%}), increased median number of practice pharmacist consultations (4 v 2 per patient) and mental health diagnosis (85{\%} v 51{\%}).ConclusionOur observed abstinence rate was comparable or better than those obtained by practice nurses, community pharmacists and outpatient pharmacists, indicating the general practice pharmacist provided an effective smoking cessation intervention. A larger randomised trial is warranted.",
keywords = "General practice, pharmacist, primary care, smoking, smoking cessation",
author = "Deeks, {Louise S.} and Sam Kosari and Anne Develin and Peterson, {Gregory M.} and Mark Naunton",
year = "2019",
month = "1",
day = "1",
doi = "10.1017/jsc.2019.3",
language = "English",
pages = "1--4",
journal = "Journal of Smoking Cessation",
issn = "1834-2612",
publisher = "Australian Academic Press",

}

Smoking cessation and the general practice pharmacist. / Deeks, Louise S.; Kosari, Sam; Develin, Anne; Peterson, Gregory M.; Naunton, Mark.

In: Journal of Smoking Cessation, 01.01.2019, p. 1-4.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Smoking cessation and the general practice pharmacist

AU - Deeks, Louise S.

AU - Kosari, Sam

AU - Develin, Anne

AU - Peterson, Gregory M.

AU - Naunton, Mark

PY - 2019/1/1

Y1 - 2019/1/1

N2 - IntroductionRoles for pharmacists in general practice are developing in Australia. It is known that pharmacists can provide effective smoking cessation services in other settings but evidence in general practice is lacking.AimTo determine whether a pharmacist can provide effective smoking cessation services within general practice.MethodData from smoking cessation consultations were obtained for 66 consecutive patients seen by one practice pharmacist. The pharmacist tailored interventions to the individual. Medication was offered in collaboration with community pharmacists and general practitioners. Quit coaching, based on motivational interviewing, was conducted. Smoking status was ascertained at least 6 months after the intended quit date and verified by a carbon monoxide breath test where possible.ResultsThe patients' median age was 43 years (range 19-74 years); 42 were females (64%). At baseline, the median (i) number of pack years smoked was 20 (range: 1-75); (ii) Fagerstrom Test of dependence score was 6 (1-10); and (iii) number of previous quit attempts was 3 (0-10). Follow-up after at least 6 months determined a self-reported point prevalence abstinence rate of 30% (20/66). Of all patients who reported to be abstinent, 65% (13/20) were tested for carbon monoxide breath levels and were all below 7 ppm. The biochemically verified smoking abstinence rate was therefore 20% overall (13/66). Successful quit attempts were associated with varenicline recommendation (69% v 25%), increased median number of practice pharmacist consultations (4 v 2 per patient) and mental health diagnosis (85% v 51%).ConclusionOur observed abstinence rate was comparable or better than those obtained by practice nurses, community pharmacists and outpatient pharmacists, indicating the general practice pharmacist provided an effective smoking cessation intervention. A larger randomised trial is warranted.

AB - IntroductionRoles for pharmacists in general practice are developing in Australia. It is known that pharmacists can provide effective smoking cessation services in other settings but evidence in general practice is lacking.AimTo determine whether a pharmacist can provide effective smoking cessation services within general practice.MethodData from smoking cessation consultations were obtained for 66 consecutive patients seen by one practice pharmacist. The pharmacist tailored interventions to the individual. Medication was offered in collaboration with community pharmacists and general practitioners. Quit coaching, based on motivational interviewing, was conducted. Smoking status was ascertained at least 6 months after the intended quit date and verified by a carbon monoxide breath test where possible.ResultsThe patients' median age was 43 years (range 19-74 years); 42 were females (64%). At baseline, the median (i) number of pack years smoked was 20 (range: 1-75); (ii) Fagerstrom Test of dependence score was 6 (1-10); and (iii) number of previous quit attempts was 3 (0-10). Follow-up after at least 6 months determined a self-reported point prevalence abstinence rate of 30% (20/66). Of all patients who reported to be abstinent, 65% (13/20) were tested for carbon monoxide breath levels and were all below 7 ppm. The biochemically verified smoking abstinence rate was therefore 20% overall (13/66). Successful quit attempts were associated with varenicline recommendation (69% v 25%), increased median number of practice pharmacist consultations (4 v 2 per patient) and mental health diagnosis (85% v 51%).ConclusionOur observed abstinence rate was comparable or better than those obtained by practice nurses, community pharmacists and outpatient pharmacists, indicating the general practice pharmacist provided an effective smoking cessation intervention. A larger randomised trial is warranted.

KW - General practice

KW - pharmacist

KW - primary care

KW - smoking

KW - smoking cessation

UR - http://www.scopus.com/inward/record.url?scp=85064009644&partnerID=8YFLogxK

U2 - 10.1017/jsc.2019.3

DO - 10.1017/jsc.2019.3

M3 - Article

SP - 1

EP - 4

JO - Journal of Smoking Cessation

JF - Journal of Smoking Cessation

SN - 1834-2612

ER -